Search research articles
Contact Us
Filters
Showing results (1281-1290 of 1,433) with videos related to
Page
of 144
Sort By:
Plos Neglected Tropical Diseases
|
June 21, 2013
Oxidative stress and DNA lesions: the role of 8-oxoguanine lesions in Trypanosoma cruzi cell viability
Pedro H N Aguiar, Carolina Furtado, Bruno M Repolês, et al.
Cancers
|
June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)
Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
Breast (Edinburgh, Scotland)
|
February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model
Luisa Carbognin, Michele Simbolo, Anna Caliò, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2023
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial
Luca Malorni, Giampaolo Bianchini, Roberta Caputo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2017
Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey
S Banerjee, R Califano, J Corral, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
M V Dieci, P Conte, G Bisagni, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohort
Luca Visani, Ivica Ratosa, Rupert Bartsch, et al.
Current Oncology (Toronto, Ont.)
|
February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT
Angelo Maggio, Tiziana Rancati, Marco Gatti, et al.
Frontiers in Immunology
|
January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2025
Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trial
Federica Miglietta, Manon De Graaf, Claudio Vernieri, et al.
Page
of 144
Search research articles
Search
Showing results (1281-1290 of 1,433) with videos related to
Sort By:
Page
of 144
Plos Neglected Tropical Diseases
|
June 21, 2013
Oxidative stress and DNA lesions: the role of 8-oxoguanine lesions in Trypanosoma cruzi cell viability
Pedro H N Aguiar, Carolina Furtado, Bruno M Repolês, et al.
Cancers
|
June 2, 2021
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)
Ercole Mazzeo, Luca Triggiani, Luca Frassinelli, et al.
Breast (Edinburgh, Scotland)
|
February 7, 2020
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model
Luisa Carbognin, Michele Simbolo, Anna Caliò, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2023
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial
Luca Malorni, Giampaolo Bianchini, Roberta Caputo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2017
Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey
S Banerjee, R Califano, J Corral, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
M V Dieci, P Conte, G Bisagni, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohort
Luca Visani, Ivica Ratosa, Rupert Bartsch, et al.
Current Oncology (Toronto, Ont.)
|
February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT
Angelo Maggio, Tiziana Rancati, Marco Gatti, et al.
Frontiers in Immunology
|
January 26, 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2025
Prognosis and biological characteristics of ER-low metastatic breast cancer: results from a multicenter cohort and the TONIC trial
Federica Miglietta, Manon De Graaf, Claudio Vernieri, et al.
Page
of 144